Early and late-onset effect of chronic stress on vascular function in mice: A possible model of the impact of depression on vascular disease in aging

American Journal of Geriatric Psychiatry

Volumn 19, Issue 4, 2011, Pages 335-346

  Isingrini, Elsa ^a,b   Belzung, Catherine ^a,b   D'Audiffret, Alexandre ^c,d   Camus, Vincent ^a,b,e  

^a CHRU de Tours   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c WEST VIRGINIA UNIVERSITY   (United States)

^d WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY HOSPITAL OF TOURS   (France)

Author keywords

aging; cardiovascular disease; chronic stress; depression; rodent model; vascular markers

Indexed keywords

FLUOXETINE; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; SODIUM CHLORIDE; VASCULAR CELL ADHESION MOLECULE 1;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; ENZYME LINKED IMMUNOSORBENT ASSAY; GROOMING; MALE; MOTIVATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SELF CARE; UNPREDICTABLE CHRONIC MILD STRESS; VASCULAR DISEASE;

EID: 79953730568     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/JGP.0b013e318202bc42     Document Type: Article

References (66)

1. Camus V, Kraehenbuhl H, Preisig M, et al: Geriatric depression and vascular diseases: what are the links? J Affect Disord 2004; 81:1-16. (Pubitemid 38759321)
2. Nemeroff CB: The curiously strong relationship between cardiovascular disease and depression in the elderly. Am J Geriatr Psychiatry 2008; 16:857-860.
3. Hemingway H, Marmot M: Evidence based cardiology: psychosocial factors in the aetiology and prognosis of coronary heart disease. Systematic review of prospective cohort studies. BMJ 1999; 318:1460-1467; Clinical research ed. (Pubitemid 29243707)
4. Rugulies R: Depression as a predictor for coronary heart disease. A review and meta-analysis. Am J Prev Med 2002; 23:51-61. (Pubitemid 34687133)
5. Jonas BS, Mussolino ME: Symptoms of depression as a prospective risk factor for stroke. Psychosom Med 2000; 62:463-471. (Pubitemid 30604788)
6. Lett HS, Blumenthal JA, Babyak MA, et al: Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med 2004; 66:305-315. (Pubitemid 38668397)
7. Pratt LA, Ford DE, Crum RM, et al: Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up. Circulation 1996; 94:3123-3129.
8. Ford DE, Mead LA, Chang PP, et al: Depression is a risk factor for coronary artery disease in men: the precursors study. Arch Intern Med 1998; 158:1422-1426. (Pubitemid 28317757)
9. Isingrini E, Desmidt T, Belzung C, et al: Endothelial dysfunction: a potential therapeutic target for geriatric depression and brain amyloid deposition in Alzheimer's disease? Curr Opin Invest Drugs 2009; 10:46-55.
10. Lahlou-Laforet K, Alhenc-Gelas M, Pornin M, et al: Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease. Am J Cardiol 2006; 97:1287-1291. (Pubitemid 44316788)
11. Thomas AJ, Ferrier IN, Kalaria RN, et al: Elevation in late-life depression of intercellular adhesion molecule-1 expression in the dorsolateral prefrontal cortex. Am J Psychiatry 2000; 157:1682-1684.
12. Thomas AJ, Perry R, Kalaria RN, et al: Neuropathological evidence for ischemia in the white matter of the dorsolateral prefrontal cortex in late-life depression. Int J Geriatr Psychiatry 2003; 18:7-13. (Pubitemid 36131222)
13. Thomas AJ, Morris C, Davis S, et al: Soluble cell adhesion molecules in late-life depression. Int Psychogeriatr 2007; 19:914-920. (Pubitemid 47295891)
14. Dimopoulos N, Piperi C, Salonicioti A, et al: Elevation of plasma concentration of adhesion molecules in late-life depression. Int J Geriatr Psychiatry 2006; 21:965-971. (Pubitemid 44596391)
15. Krieglstein CF, Granger DN: Adhesion molecules and their role in vascular disease. Am J Hypertens 2001; 14:44S-54S. (Pubitemid 32506696)
16. Ridker PM, Rifai N, Stampfer MJ, et al: Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101:1767-1772. (Pubitemid 30213096)
17. Ridker PM, Hennekens CH, Buring JE, et al: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342:836-843. (Pubitemid 30165206)
18. Kim JS: Cytokines and adhesion molecules in stroke and related diseases. J Neurol Sci 1996; 137:69-78. (Pubitemid 26172036)
19. Kop WJ, Gottdiener JS, Tangen CM, et al: Inflammation and coagulation factors in persons > 65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol 2002; 89:419-424. (Pubitemid 34142517)
20. Panagiotakos DB, Pitsavos C, Chrysohoou C, et al: Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA study. Eur Heart J 2004; 25:492-499. (Pubitemid 38524274)
21. Shimbo D, Chaplin W, Crossman D, et al: Role of depression and inflammation in incident coronary heart disease events. Am J Cardiol 2005; 96:1016-1021. (Pubitemid 41362531)
22. Galis ZS, Johnson C, Godin D, et al: Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling. Circ Res 2002; 91:852-859. (Pubitemid 35285084)
23. Garvin P, Nilsson L, Carstensen J, et al: Plasma levels of matrix metalloproteinase-9 are independently associated with psychosocial factors in a middle-aged normal population. Psychosom Med 2009; 71:292-300.
24. Willner P: Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology 1997; 134:319-329. (Pubitemid 28023396)
25. Willner P, Towell A, Sampson D, et al: Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology 1987; 93:358-364. (Pubitemid 17160661)
26. Ducottet C, Griebel G, Belzung C: Effects of the selective nonpeptide corticotropin-releasing factor receptor 1 antagonist antalarmin in the chronic mild stress model of depression in mice. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27:625-631. (Pubitemid 36645063)
27. Yalcin I, Aksu F, Belzung C: Effects of desipramine and tramadol in a chronic mild stress model in mice are altered by yohimbine but not by pindolol. Eur J Pharmacol 2005; 514:165-174. (Pubitemid 40720357)
28. Willner P, Muscat R, Papp M: Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci Biobehav Rev 1992; 16:525-534.
29. Santarelli L, Saxe M, Gross C, et al: Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003; 301:805-809. (Pubitemid 36962615)
30. De Boer SF, Koolhaas JM: Defensive burying in rodents: ethology, neurobiology and psychopharmacology. Eur J Pharmacol 2003; 463:145-161. (Pubitemid 36205077)
31. Capone F, Venerosi A, Puopolo M, et al: Behavioral responses of 129/Sv, C57BL/6J and DBA/2J mice to a non-predator aversive olfactory stimulus. Acta Neurobiol Exp (Wars) 2005; 65:29-38. (Pubitemid 40525044)
32. Ibarguen-Vargas Y, Surget A, Touma C, et al: Multifaceted strainspecific effects in a mouse model of depression and of antidepressant reversal. Psychoneuroendocrinology 2008; 33:1357-1368.
33. Frank E, Thase ME: Natural history and preventative treatment of recurrent mood disorders. Annu Rev Med 1999; 50:453-468. (Pubitemid 29117078)
34. Frank E, Kupfer DJ, Perel JM, et al: Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1990; 47:1093-1099.
35. Carney RM, Freedland KE: Treatment-resistant depression and mortality after acute coronary syndrome. Am J Psychiatry 2009; 166:410-417.
36. Paigen B, Ishida BY, Verstuyft J, et al: Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice. Arteriosclerosis 1990; 10:316-323. (Pubitemid 20103595)
37. Nilupul Perera M, Ma HK, Arakawa S, et al: Inflammation following stroke. J Clin Neurosci 2006; 13:1-8. (Pubitemid 43061121)
38. Grippo AJ, Francis J, Beltz TG, et al: Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia. Physiol Behav 2005; 84:697-706. (Pubitemid 40693431)
39. Mast BT,Neufeld S, MacNeill SE, et al: Longitudinal support for the relationship between vascular risk factors and late-life depressive symptoms. Am J Geriatr Psychiatry 2004; 12:93-101. (Pubitemid 38082399)
40. Li C, Ford ES, Strine TW, et al: Prevalence of depression among U.S. adults with diabetes: findings from the 2006 behavioral risk factor surveillance system. Diabetes Care 2008; 31:105-107.
41. Sharkey JR, Ory MG, Wang S: Double strain of severe obesity and depression on perception of increased diabetes burden among homebound older women. J Nutr Elder 2006; 26:123-130. (Pubitemid 47442925)
42. Lehto S, Koukkunen H, Hintikka J, et al: Depression after coronary heart disease events. Scand Cardiovasc J 2000; 34:580-583. (Pubitemid 32094362)
43. Glassman AH, Helzer JE, Covey LS, et al: Smoking, smoking cessation, and major depression. JAMA 1990; 264:1546-1549. (Pubitemid 20303384)
44. Camacho TC, Roberts RE, Lazarus NB, et al: Physical activity and depression: evidence from the Alameda County Study. Am J Epidemiol 1991; 134:220-231.
45. Eaton WW, Armenian H, Gallo J, et al: Depression and risk for onset of type II diabetes. A prospective population-based study. Diabetes Care 1996; 19:1097-1102. (Pubitemid 26334257)
46. Kawakami N, TakatsukaN, Shimizu H, et al: Depressive symptoms and occurrence of type 2 diabetes among Japanese men. Diabetes Care 1999; 22:1071-1076. (Pubitemid 29293958)
47. Gawaz M, Langer H,May AE: Platelets in inflammation and atherogenesis. J Clin Invest 2005; 115:3378-3384. (Pubitemid 43121822)
48. Gawaz M, Brand K, Dickfeld T, et al: Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis. Atherosclerosis 2000; 148:75-85.
49. Gawaz M: Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium. Cardiovasc Res 2004; 61:498-511. (Pubitemid 38210155)
50. Henn V, Slupsky JR, Grafe M, et al: CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998; 391:591-594. (Pubitemid 28157601)
51. May AE, Kalsch T, Massberg S, et al: Engagement of glycoprotein IIb/IIIa (alpha(IIb)beta3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells. Circulation 2002; 106:2111-2117. (Pubitemid 35192818)
52. Mian OS, Baltzopoulos V, Minetti AE, et al: The impact of physical training on locomotor function in older people. Sports Med 2007; 37:683-701. (Pubitemid 47173810)
53. Galson SK: Self-management programs: one way to promote healthy aging. Public Health Rep 2009; 124:478-480.
54. Mehta J, Mehta P, Lawson D, et al: Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations. J Am Coll Cardiol 1987; 9:263-268. (Pubitemid 17013784)
55. Gleerup G, Winther K: The effect of ageing on platelet function and fibrinolytic activity. Angiology 1995; 46:715-718.
56. Yildiz O: Vascular smooth muscle and endothelial functions in aging. Ann N Y Acad Sci 2007; 1100:353-360. (Pubitemid 47092672)
57. Ferrari AU, Radaelli A, Centola M: Invited review: aging and the cardiovascular system. J Appl Physiol 2003; 95:2591-2597. (Pubitemid 37445007)
58. Lundberg MS, Crow MT: Age-related changes in the signaling and function of vascular smooth muscle cells. Exp Gerontol 1999; 34:549-557. (Pubitemid 29383873)
59. Challah M, Nadaud S, Philippe M, et al: Circulating and cellular markers of endothelial dysfunction with aging in rats.AmJ Physiol 1997; 273:H1941-H1948.
60. Zou Y, Jung KJ, Kim JW, et al: Alteration of soluble adhesion molecules during aging and their modulation by calorie restriction. FASEB J 2004; 18:320-322.
61. Zou Y, Yoon S, Jung KJ, et al: Upregulation of aortic adhesion molecules during aging. J Gerontol 2006; 61:232-244.
62. Lindsey ML, Goshorn DK, Squires CE, et al: Age-dependent changes in myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase profiles and fibroblast function. Cardiovasc Res 2005; 66:410-419. (Pubitemid 40471056)
63. Roose SP, Glassman AH, Attia E, et al: Cardiovascular effects of fluoxetine in depressed patients with heart disease. Am J Psychiatry 1998; 155:660-665. (Pubitemid 28225407)
64. Glassman AH, O'Connor CM, Califf RM, et al: Sertraline treatmentof major depression in patients with acute MI or unstable angina. JAMA 2002; 288:701-709. (Pubitemid 34848222)
65. Serebruany VL, Glassman AH, Malinin AI, et al: Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy. Circulation 2003; 108:939-944. (Pubitemid 37048222)
66. Van Zyl LT, Lesperance F, Frasure-Smith N, et al: Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study. J Thromb Thrombolysis 2009; 27:48-56